首页> 美国卫生研究院文献>Cancer Science >Long noncoding RNA ANRIL promotes the malignant progression of cholangiocarcinoma by epigenetically repressing ERRFI1 expression
【2h】

Long noncoding RNA ANRIL promotes the malignant progression of cholangiocarcinoma by epigenetically repressing ERRFI1 expression

机译:长度非编码RNA anril通过表现出Errfi1表达来促进胆管癌的恶性进展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Long noncoding RNAs (lncRNAs) have recently been verified to have significant regulatory functions in many types of human cancers. The lncRNA is transcribed from the gene cluster in the opposite direction. Whether can act as an oncogenic molecule in cholangiocarcinoma (CCA) remains unknown. Our data show that knockdown greatly inhibited CCA cell proliferation and migration in vitro and in vivo. According to the results of RNA sequencing analysis, knockdown dramatically altered target genes associated with the cell cycle, cell proliferation, and apoptosis. By binding to a component of the epigenetic modification complex enhancer of zeste homolog 2 (EZH2), could maintain lysine residue 27 of histone 3 (H3K27me3) levels in the promoter of ERBB receptor feedback inhibitor 1 ( ), which is a tumor suppressor gene in CCA. In this way, expression was suppressed in CCA cells. These data verified the key role of the epigenetic regulation of in CCA oncogenesis and indicate its potential as a target for CCA intervention.
机译:最近已经验证了长时间的NOODING RNA(LNCRNA)以在许多类型的人类癌症中具有显着的监管功能。 LNCRNA以相反方向从基因簇转录。是否可以作为胆管癌(CCA)中的致癌分子仍然未知。我们的数据表明,敲低在体外和体内迁移的敲低抑制了CCA细胞增殖和迁移。根据RNA测序分析的结果,显着改变与细胞周期,细胞增殖和细胞凋亡相关的靶基因。通过结合Zeste同源物2(EZH2)的表观遗传改性复合增强剂,可以在ERBB受体反馈抑制剂1()的启动子中保持组蛋白3(H3K27ME3)水平的赖氨酸残基27,其是肿瘤抑制基因CCA。以这种方式,在CCA细胞中抑制了表达。这些数据验证了CCA蜂癌的表观遗传调节的关键作用,并表明其作为CCA干预目标的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号